About PGN-EDODM1. PGN-EDODM1, PepGen's investigational candidate in development for the treatment of myotonic dystrophy type 1 (DM1), utilizes the Company's proprietary EDO technology to deliver a ...

Mubadala, PGN advance gas and LNG studies for giant discoveries. Duo to evaluate liquefied natural gas and pipeline infrastructure options for fast-track South Andaman project in Indonesia.